Clinical Trials in Chicago

Showing 6061-6080 of 15,574 trials

Memesto Wearable Device for Persons With Dementia

NCT05153161

An estimated 70% of the 7.2+ million people in the U.S. with Alzheimer's Disease and Alzheimer's Disease-Related Dementias experience agitation, characterized by poorly organized and purposeless psychomotor activity that diminishes their quality of life. The goal of this Small Business Innovation Research (SBIR) project is to develop a wearable therapy device that automatically senses rising agitation, and alerts caregivers while deploying calming voice and music therapy to help them avoid crisis level behavior. This device will improve health outcomes for AD/ADRD sufferers and reduce the substantial stress suffered by their caregivers.

Alzheimer Disease

Edgewater Safety Systems, Inc.9 participantsStarted Aug 2022

Chicago, Illinois, United States

COMPLETEDPhase 2/32.2 miles

A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Esophagitis

NCT04322708

This is a Phase 2/3, multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of lirentelimab (AK002) given monthly for 6 doses in adult and adolescent patients with active eosinophilic esophagitis. Subjects who complete the randomized, double-blind, placebo-controlled treatment may have the option to receive 6 doses of open-label lirentelimab (AK002) through the OLE Period of the study.

Eosinophilic Esophagitis

Allakos Inc.277 participantsStarted Jul 2020

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Gilbert, Arizona, United States +75 more locations

Memesto Wearable Device for Persons With Dementia

A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Esophagitis

Find Trials by Condition in Chicago

Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium.

Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss

Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine

A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)

Transseptal vs Retrograde Aortic Ventricular Entry to Reduce Systemic Emboli

Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ Cancers

A Study of the Effectiveness And Safety Of Lidoderm® As Add-On Treatment in Patients With Postherpetic Neuralgia, Diabetic Neuropathy, or Low Back Pain

Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain

Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia

A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer

VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Disrupt PAD+ Study With the Shockwave Medical M5+ Peripheral IVL System

Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma

MSB11022 in Moderate to Severe Chronic Plaque Psoriasis

A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions

Nab-Sirolimus in Combination With FOLFOX & BEV as 1st Line Therapy in Patients With Advanced or Metastatic Colorectal Cancer